Simplify Logo
Zeiss

Zeiss

Supplies lithography optics for semiconductor manufacturing

Multi-site Environmental Health and Safety & Radiation Safety Manager

Full-Time
No salary listed
Senior, Expert
Bachelor's, Associate's
Wixom, MI, USA
In Person

On-site Monday through Friday; up to 20% travel and periodic visits to supported sites.

Company Does Not Provide H1B Sponsorship

About the job

Requirements
  • An associate degree is required.
  • A minimum of 8 years of progressive experience in Environmental Health and Safety and/or radiation safety is required.
  • Demonstrated expertise in Occupational Safety and Health Administration, Environmental Protection Agency, Department of Transportation, Resource Conservation and Recovery Act, and Nuclear Regulatory Commission or Agreement State radiation regulations is required.
  • Experience implementing ISO 14001 or similar management systems is required.
  • Strong analytical and problem-solving skills and the ability to lead investigations and root cause analysis are required.
  • The ability to lead and deliver safety, radiation protection, gauge safety, hazardous materials, emergency response, and annual refresher training is required.
  • Proficiency with Microsoft Office, including Word, Excel, PowerPoint, and Outlook, and Environmental Health and Safety management tools is required.
  • The role requires the ability to work independently, manage multiple priorities, and collaborate across functions and sites.
  • The role requires the ability to lift 30–50 pounds without assistance and use required personal protective equipment.
  • The role requires on-call availability and the ability to work outside normal business hours as needed.
Responsibilities
  • Lead Environmental Health and Safety, radiation safety, and related regulatory compliance programs for the supported sites.
  • Design, implement, and maintain the Employee Health and Safety management system, including policies, procedures, and standards.
  • Develop and deliver safety training and track completion.
  • Lead Emergency Response Team programs and emergency preparedness, including drills and emergency plans, in collaboration with Facilities.
  • Conduct and document GEMBA safety walks and inspections and track findings through closure.
  • Lead incident reporting, investigation, root cause analysis, and implementation of corrective and preventive actions.
  • Maintain Occupational Safety and Health Administration-required logs and reporting and interface with regulators as needed.
  • Maintain and implement ISO 14001 environmental management requirements for covered sites.
  • Own and manage environmental permits and compliance obligations covering water, stormwater, wastewater, air, and waste.
  • Manage Resource Conservation and Recovery Act hazardous waste programs and associated documentation, labeling, storage, and disposal.
  • Maintain Department of Transportation compliance for hazardous materials shipping, including training and documentation.
  • Define and oversee hazardous waste and recycling programs and coordinate with Facilities and vendors.
  • Track and report environmental performance metrics and support corporate sustainability initiatives.
  • Serve as Radiation Safety Officer for licensed activities and ensure compliance with Nuclear Regulatory Commission or Agreement State regulations and license conditions.
  • Ensure radiation exposures are as low as reasonably achievable and comply with applicable regulations, including 10 CFR Part 20.
  • Develop, maintain, and distribute radiation protection procedures and ensure implementation in daily operations.
  • Verify that individuals installing, maintaining, or servicing devices containing sealed sources are properly licensed and trained.
  • Determine monitoring requirements and manage personnel dosimetry programs, including badge issuance, exchange, and record review.
  • Perform or coordinate required radiation surveys and dose assessments and maintain related records.
  • Conduct and document annual or more frequent audits of the radiation protection program and drive corrective actions.
  • Manage licensing activities, including initial applications, amendments, renewals, and decommissioning or disposal of licensed equipment.
  • Review and approve new uses and users of radioactive equipment before first use.
  • Provide periodic on-site supervision and technical guidance on radiation safety practices.
  • Lead risk assessments, including job safety analyses, job hazard analyses, ergonomic, chemical, and radiation assessments, and ensure controls are implemented.
  • Maintain Safety Data Sheet systems and ensure accessibility for employees.
  • Monitor regulatory changes and corporate requirements, update programs, and communicate changes to stakeholders.
  • Ensure alignment and compliance with ZEISS Security, Safety, and Corporate Policies.
  • Define Environmental Health and Safety and radiation requirements affecting facility design, equipment, layouts, and operations.
  • Implement engineering controls, signage, storage areas, ventilation, and other physical safeguards with Facilities and facility leads.
  • Plan Environmental Health and Safety aspects of projects, relocations, or new installations.
  • Coordinate emergency response infrastructure, including alarms, evacuation routes, and spill response kits.
  • Provide Environmental Health and Safety and radiation input into vendor and contractor controls and ensure contractors meet site requirements.
  • Work directly with the Management Team to satisfy facility needs and perform related duties assigned by the Head of Business Excellence, Quality, and Digital Solutions.
Desired Qualifications
  • A bachelor's degree in Occupational Safety, Industrial Hygiene, Environmental Science, Engineering, or a related field.
  • Relevant professional certifications such as Certified Safety Professional, Certified Industrial Hygienist, Certified Hazardous Materials Manager, or recognized Radiation Safety Officer training.
  • Experience in a manufacturing or technical environment.

About the company

Zeiss SMT designs and makes high-precision optical systems for semiconductor manufacturing, including lithography optics, photomask solutions, and process-control components. Its products are used in lithography equipment to project circuit patterns onto silicon wafers, with responsibilities spanning advanced optics, mask technology, and monitoring tools that ensure precise, repeatable imaging.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$1.1B

Headquarters

Oberkochen, Germany

Founded

2001

Get referred to Zeiss

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ZEISS SMT opened its Korea Innovation Center in July 2026, deepening customer access.
  • July 24, 2026 capacity expansion adds 25,000 square meters in Oberkochen.
  • ASML expects 2027 EUV output growth, with Zeiss optics capacity already expanding.

What critics are saying

  • ASML bought €4.41 billion from Zeiss in 2025; customer concentration is extreme.
  • A prolonged Oberkochen outage would halt ASML production within months.
  • Monument Peak sued Zeiss on February 6, 2026 over Kodak patents.

What makes Zeiss unique

  • ZEISS SMT remains ASML's sole EUV optics supplier in 2026.
  • Oberkochen and Wetzlar are the only places building ASML optical columns.
  • High-NA EUV optics from ZEISS anchor sub-2nm lithography for Intel and TSMC.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 27th, 2026
ZEISS launches DORC EVA NEXUS cataract system at ESCRS in London

ZEISS Medical Technology has launched a cataract-only configuration of its DORC EVA NEXUS ophthalmic surgical system. The system features a cataract grade selection with up to four programmable presets, allowing surgeons to optimise phaco, aspiration, and irrigation settings for each surgical step. The solution includes VacuFlow VTi pump, SMART IOP, and EVA EQUIPHACO technologies, designed to provide streamlined performance, stability, and control during procedures. It integrates with the ZEISS Cataract Workflow portfolio. The system debuted at the European Society of Cataract and Refractive Surgeons congress in London. It will become available in select European countries from September 2026, with global rollout pending regulatory approvals. The technology expands ZEISS's existing EVA NEXUS platform, which previously focused on retina workflows.

PR Newswire
Aug 19th, 2026
ZEISS CLINIC 360 receives FDA clearance for cloud-based ophthalmic data management software

ZEISS Medical Technology announced FDA 510(k) clearance for ZEISS CLINIC 360, a cloud-based software solution that aggregates ophthalmic clinical data and provides advanced analytics. The browser-based platform combines diagnostic and medical data into a comprehensive patient view, helping clinicians evaluate disease progression and support treatment decisions. The solution integrates data from DICOM-enabled diagnostic devices, including ZEISS's CIRRUS, CLARUS and HFA systems, as well as third-party devices. It features disease-based summaries, interactive analysis tools, and collaboration capabilities through ZEISS Collaborative Care. ZEISS CLINIC 360 will be available in the US in early autumn 2026 on a subscription basis with low upfront costs. The platform complements ZEISS FORUM, the company's on-premise data management system, giving providers flexibility in choosing their preferred infrastructure approach.

ZEISS
Aug 5th, 2026
ZEISS leads $2.5M investment in SeeTrue Technologies for miniaturised eye-tracking tech

ZEISS Ventures led a €2.2 million investment round in SeeTrue Technologies, a Finnish deep-tech company developing miniaturised eye-tracking technology. The funding will accelerate commercialisation of SeeTrue's ultra-low-power eye-sensing architecture for next-generation interfaces in smart optical systems and eyewear. SeeTrue's proprietary technology combines miniaturised sensing hardware with optimised embedded processing, enabling scalable eye-sensing capabilities with low power consumption and small hardware footprint. The technology supports gaze-based interaction and attention-aware computing across healthcare, industrial, and smart eyewear applications. The investment round includes participation from Superhero Capital and North Karelia Growth Fund, managed by Redstone Nordics. Founded in 2018 and based in Joensuu, Finland, SeeTrue develops ultra-miniature eye-tracking technology for medical optical systems, vision care, and smart wearables.

PR Newswire
Jun 11th, 2026
ZEISS completes early implantations of AT LUCIA toric 721P intraocular lens

ZEISS Medical Technology has announced successful early clinical implantations of its AT LUCIA toric 721P intraocular lens, designed to treat cataracts whilst correcting astigmatism. The company is conducting an early-access clinical trial with experienced surgeons across six European countries. The lens combines an aspheric bitoric optic with a patented non-constant aberration design on a fully preloaded, hydrophobic platform. Surgeons have reported positive early impressions, highlighting the lens's precision, stability and surgical handling. Currently CE marked, the AT LUCIA toric 721P will be showcased at the International Congress of German Ophthalmic Surgery in Nuremberg from 18–20 June 2026. The lens is expected to be commercially available in select European countries later this year.

ZEISS
May 28th, 2026
ZEISS invests in Maculaser to advance temperature-controlled retinal laser therapy

ZEISS Ventures has invested in Maculaser, a Finnish medtech company developing temperature-controlled retinal laser therapy, through a funding round co-led with M2care. The investment will support clinical development of the company's personalized treatment for retinal diseases. Founded in 2020 and based on research from Aalto University, Maculaser has developed patented technology that provides real-time temperature control during laser treatment. The non-damaging approach activates natural cellular defence mechanisms, targeting affected retinal areas early to delay or prevent progression of age-related macular degeneration and diabetic maculopathy. The technology aims to shift retinal care from managing late-stage damage to proactive vision preservation, offering an outpatient procedure that integrates into regular eye care. Maculaser plans to bring the treatment into clinical practice to benefit millions of patients worldwide.